These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35812114)

  • 1. A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB.
    Bano S; Nawaz A; Numan A; Hassan MA; Shafique MBA
    Front Neurol; 2022; 13():908584. PubMed ID: 35812114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.
    Swaminathan A; du Cros P; Seddon JA; Mirgayosieva S; Asladdin R; Dusmatova Z
    BMC Infect Dis; 2017 Jun; 17(1):417. PubMed ID: 28606115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid induced toxic optic neuropathy in drug resistant tuberculosis-A case series.
    Vallabhaneni S; Mendonca TM; Nayak RR; Kamath G; Kamath A
    Indian J Tuberc; 2024; 71 Suppl 1():S5-S9. PubMed ID: 39067955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optic neuropathy secondary to Linezolid for multidrug-resistant mycobacterial spinal tuberculosis.
    Agrawal R; Addison P; Saihan Z; Pefkianaki M; Pavesio C
    Ocul Immunol Inflamm; 2015 Feb; 23(1):90-2. PubMed ID: 24432953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Severe and Long-lasting Linezolid-induced Optic Neuropathy Reversible?
    Lee S; Kang BH; Ryu WY; Um SJ; Roh MS; Son C
    Intern Med; 2018 Dec; 57(24):3611-3613. PubMed ID: 30101940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid-induced optic neuropathy in XDR pulmonary TB: A case series.
    Srivastava A; Kshetrimayum S; Gupta SK; Kant S
    Indian J Tuberc; 2017 Apr; 64(2):129-133. PubMed ID: 28410695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid-induced optic neuropathy.
    Karuppannasamy D; Raghuram A; Sundar D
    Indian J Ophthalmol; 2014 Apr; 62(4):497-500. PubMed ID: 24088636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India.
    Mehta S; Das M; Laxmeshwar C; Jonckheere S; Thi SS; Isaakidis P
    PLoS One; 2016; 11(9):e0162138. PubMed ID: 27611434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid-Induced Toxic Optic Neuropathy.
    Aljebreen MA; Alotaibi AK; Alrobaian M
    Middle East Afr J Ophthalmol; 2020; 27(4):235-237. PubMed ID: 33814822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.
    Jaspard M; Butel N; El Helali N; Marigot-Outtandy D; Guillot H; Peytavin G; Veziris N; Bodaghi B; Flandre P; Petitjean G; Caumes E; Pourcher V
    Emerg Infect Dis; 2020 Aug; 26(8):1792-1800. PubMed ID: 32687026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis.
    Yuan Y; Li J; Chen Y; Cai Q; Xu Y; Lin L; Lang Y; Guo S; Zhang R; Cai X
    Front Pharmacol; 2022; 13():946058. PubMed ID: 36160387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China.
    Zhang P; Li W; Liu M; Zhan S; Zhang H; Deng G; Chen X
    Infect Drug Resist; 2022; 15():2617-2624. PubMed ID: 35634579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
    Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
    Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF; Scott C; True L; Raftery A; Flood J; Mase S
    Clin Infect Dis; 2010 Jan; 50(1):49-55. PubMed ID: 19947856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B; Sandven P; Brubakk O
    J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid-induced optic neuropathy.
    Saijo T; Hayashi K; Yamada H; Wakakura M
    Am J Ophthalmol; 2005 Jun; 139(6):1114-6. PubMed ID: 15953450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum.
    Saroha D; Garg D; Singh AK; Dhamija RK
    Indian J Tuberc; 2020 Jul; 67(3):389-392. PubMed ID: 32825876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid toxic optic neuropathy: A case report and review of visual prognosis.
    Toolan KJ; Fondriest J; Keenan K; Mizen T; Stosic M
    Am J Ophthalmol Case Rep; 2023 Dec; 32():101922. PubMed ID: 37680308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid optic neuropathy.
    Miller HV; Cao AA; McClelland CM; Lee MS
    Curr Opin Ophthalmol; 2023 Nov; 34(6):481-486. PubMed ID: 37603423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.